Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01055730 · ClinicalTrials.gov registry record
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 54
- Enrollment target
NCT01055730: Completed study, sponsored by University of California, San Francisco.
NCT01055730 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01055730 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if pulmonary rehabilitation has any effect on breathlessness, quality of life, physical function and depression in persons with interstitial lung disease.
Interventions
- OTHER Pulmonary rehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-01 |
What the finished NCT01055730 record still lists
NCT01055730 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pulmonary rehabilitation is the first listed.
NCT01055730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01055730 about?
NCT01055730 is a clinical study titled "The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease". The purpose of this study is to determine if pulmonary rehabilitation has any effect on breathlessness, quality of life, physical function and depression in persons with interstitial lung disease.
What is the current status of trial NCT01055730?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2010-02. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01055730?
The interventions under investigation include: Pulmonary rehabilitation (OTHER).
Who is sponsoring clinical trial NCT01055730?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia